CTCBIO Inc. (KOSDAQ:060590)

South Korea · Delayed Price · Currency is KRW

2,595.00

-80.00 (-2.99%)

At close: Nov 6, 2026

Market Cap	62.04B -48.0%
Revenue (ttm)	131.54B +17.2%
Net Income	7.51B
EPS	313.54
Shares Out	23.91M
PE Ratio	8.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,951
Open	2,620.00
Previous Close	2,675.00
Day's Range	2,530.00 - 2,650.00
52-Week Range	2,525.00 - 5,610.00
Beta	0.03
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1993

Employees 226

Stock Exchange KOSDAQ

Ticker Symbol 060590

Full Company Profile

Financial Performance

Financial Statements